Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compounding is still appropriate in clinical practice

B H Thiers1

  • 1Department of Dermatology, Medical University of South Carolina, Charleston, USA.

Dermatologic Clinics
|May 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Cutaneous T-cell lymphoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2003
Same author

Systemic Weber-Christian disease.

Journal of cutaneous medicine and surgery·2001
Same author

Topical tacrolimus: treatment failure in a patient with alopecia areata.

Archives of dermatology·2000
Same author

Dermatology therapy update.

The Medical clinics of North America·1999
Same author

Psoriasis therapy update.

The Western journal of medicine·1998

Dermatologists can compound topical medications when commercial products are unavailable. This practice ensures patients receive necessary custom-made treatments for skin diseases, maintaining therapeutic options.

Area of Science:

  • Dermatology
  • Pharmaceutical Sciences

Background:

  • Topical drug delivery is essential for treating skin conditions.
  • Historically, dermatologists compounded custom topical preparations for patients.
  • Commercial manufacturing has largely replaced traditional compounding.

Purpose of the Study:

  • To highlight the importance of dermatologists maintaining compounding skills.
  • To address the limitations of commercially available topical medications.
  • To advocate for the continued practice of extemporaneous compounding.

Main Methods:

  • Review of historical and current practices in topical drug preparation.
  • Analysis of the role of pharmaceutical companies in supplying topical medications.
  • Emphasis on the dermatologist's ability to extemporaneously compound preparations.

Related Experiment Videos

Main Results:

  • Commercial topical products do not always meet patient needs.
  • Dermatologists possess the expertise to compound necessary medications.
  • Extemporaneous compounding remains a viable and necessary option.

Conclusions:

  • Dermatologists should retain and utilize compounding knowledge.
  • Compounding ensures access to essential topical medications.
  • Customized topical treatments are crucial for effective dermatological care.